← FDA DRUG APPROVALS

FDA ANDA · ANDA062501

GENTACIDIN

Sponsor: NOVARTIS

APPLICATION
ANDA062501
TYPE
ANDA
ORIGINAL APPROVAL
1984-07-26
LATEST ACTION
1997-12-09
ROUTE
OPHTHALMIC
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued

Products

GENTACIDINDiscontinued
GENTAMICIN SULFATE EQ 0.3% BASE · OINTMENT · OPHTHALMIC

Approval history

1997-12-09Manufacturing (CMC) · Supplement 2AP
1996-07-03Manufacturing (CMC) · Supplement 5AP
1996-07-03Manufacturing (CMC) · Supplement 4AP
1995-12-15Manufacturing (CMC) · Supplement 3AP
1992-06-12Labeling · Supplement 1AP
1984-07-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →